V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20027986 | 20133157 | 1.69 | 0 | 03 | 2016-03-29 | 2016-04-01 | null | 02 | N | SUNITINIB | 101257270 |
| 20028031 | 20133159 | 1.82 | 73.8 | Adjuvant (A) | 2018-07-02 | 2018-07-08 | null | 01 | N | ENZALUTAMIDE | 101591777 |
| 20028042 | 20133160 | null | 84.4 | null | 2019-03-16 | 2019-03-22 | CARBOPLATIN + PACLITAXEL + RT | null | null | CARBOPLATIN + PACLITAXEL + RT | 101208479 |
| 20028102 | 20133161 | 1.7 | 88.4 | null | 2020-03-07 | 2020-03-07 | null | 01 | null | EVEROLIMUS | 100740872 |
| 20028153 | 20133162 | 1.69 | 84 | null | 2017-05-12 | 2018-02-22 | null | 99 | null | CETUXIMAB + ENCORAFENIB | 100014075 |
| 20028186 | 20133163 | 1.68 | 86.6 | Palliative (P) | 2018-04-15 | 2018-04-16 | CISPLATIN + ETOPOSIDE | 02 | N | ATEZOLIZUMAB + BEVACIZUMAB | 101666236 |
| 20028191 | 20133164 | 1.84 | null | null | null | 2017-05-19 | null | 02 | null | CETUXIMAB + ENCORAFENIB | 100458470 |
| 20028238 | 20133165 | 1.72 | 69.6 | Curative (C) | 2017-02-12 | 2017-04-28 | null | 02 | Y | CARBOPLATIN + PACLITAXEL + RT | 100732678 |
| 20028349 | 20133166 | 1.84 | 74 | Palliative (P) | 2019-07-24 | 2019-09-08 | null | 02 | N | CARBOPLATIN + PACLITAXEL + RT | 100249156 |
| 20028380 | 20133167 | 1.67 | 86.8 | Neo-adjuvant (N) | 2019-01-21 | 2019-02-03 | null | 02 | Y | CISPLATIN | 100757730 |
| 20028422 | 20133168 | 1.52 | 83 | 03 | 2019-10-06 | 2019-11-04 | CAPECITABINE + CARBOPLATIN + Trastuzumab | 02 | N | CAPECITABINE + CARBOPLATIN + TRASTUZUMAB | 101353684 |
| 20028487 | 20133170 | 1.66 | null | Palliative (P) | 2019-11-05 | 2019-11-18 | CARBOPLATIN + PACLITAXEL + RT | 02 | null | CARBOPLATIN + PACLITAXEL + RT | 100246461 |
| 20028671 | 20133172 | 1.58 | 78 | Palliative (P) | null | 2020-04-12 | Capecitabine + Cisplatin + RT | 02 | N | CAPECITABINE + CISPLATIN + RT | 101790963 |
| 20028872 | 20133174 | 1.75 | 80.2 | null | 2021-04-12 | 2021-04-25 | CARBOPLATIN + PACLITAXEL + RT | N | null | CARBOPLATIN + PACLITAXEL + RT | 100200258 |
| 20028910 | 20133175 | 1.58 | null | Palliative (P) | 2018-08-21 | 2018-09-03 | null | 2 | N | SCALOP-2 TRIAL | 101256543 |
| 20028956 | 20133176 | 1.6 | 57.2 | null | 2015-11-25 | 2015-12-03 | null | 2 | null | MITOMYCIN INTRAVESICULAR | 100529746 |
| 20029014 | 20133177 | 1.6 | 72.6 | Palliative (P) | 2017-12-09 | 2018-01-15 | null | 02 | N | NOT MATCHED | 101161316 |
| 20029025 | 20133178 | 1.62 | 56.9 | Palliative (P) | 2019-02-10 | 2019-02-10 | null | null | null | LUTETIUM-177 | 100241537 |
| 20029065 | 20133179 | 1.59 | 69.6 | null | 2019-03-19 | 2019-04-13 | CARBOPLATIN + PACLITAXEL + RT | 02 | null | CARBOPLATIN + PACLITAXEL + RT | 101153331 |
| 20029182 | 20133180 | 1.57 | null | 03 | 2019-07-06 | 2019-07-06 | SCALOP-2 Trial | N | N | SCALOP-2 TRIAL | 100734312 |
| 20029235 | 20133181 | null | null | Palliative (P) | 2020-10-27 | 2020-12-27 | null | N | N | SCALOP-2 TRIAL | 101687945 |
| 20029260 | 20133182 | 1.66 | 70 | Palliative (P) | null | 2017-11-08 | null | 02 | N | CAPECITABINE + CETUXIMAB + IRINOTECAN | 100332183 |
| 20029304 | 20133183 | 1.76 | 64.85 | Palliative (P) | 2017-06-05 | 2017-06-13 | null | 02 | N | OCTREOTIDE | 100728754 |
| 20029305 | 20133184 | 1.85 | 65.7 | Palliative (P) | 2019-02-19 | 2019-02-27 | null | 02 | N | TRIFLURIDINE + TIPIRACIL | 101309770 |
| 20029322 | 20133185 | 1.7 | 109.5 | Palliative (P) | 2016-12-17 | 2017-01-04 | null | 02 | N | ATEZOLIZUMAB + BEVACIZUMAB | 100048230 |
| 20029348 | 20133186 | 1.75 | 89.6 | null | null | 2020-10-22 | LUTETIUM-177 | 02 | null | LENALIDOMIDE | 101614561 |
| 20029374 | 20133187 | 1.71 | 76.8 | Neo-adjuvant (N) | 2017-10-07 | 2017-10-21 | null | 02 | Y | OXALIPLATIN | 100567196 |
| 20029403 | 20133189 | 1.6 | 89 | null | 2016-09-17 | 2017-03-04 | null | 02 | null | CARBOPLATIN + PACLITAXEL + RT | 100223309 |
| 20029441 | 20133190 | 1.75 | 153 | null | 2019-05-09 | 2019-08-07 | null | N | null | EVEROLIMUS | 101808794 |
| 20029483 | 20133191 | 1.61 | 79 | Palliative (P) | 2019-05-03 | 2019-05-03 | null | 02 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100559513 |
| 20029579 | 20133192 | null | 56.1 | Palliative (P) | 2017-11-28 | 2018-01-22 | null | null | N | LENALIDOMIDE | 100831972 |
| 20029616 | 20133193 | 1.6 | 99 | Disease modification (D) | 2019-10-07 | 2019-10-13 | null | 02 | N | SCALOP-2 TRIAL | 101317396 |
| 20029632 | 20133194 | 1.61 | 57 | null | 2018-08-03 | 2018-08-03 | null | null | null | OCTREOTIDE | 100397061 |
| 20029720 | 20133196 | 1.63 | 86.8 | null | 2018-02-11 | 2018-02-24 | null | 02 | null | CISPLATIN + ETOPOSIDE | 101511925 |
| 20029737 | 20133197 | 1.83 | 89 | null | 2016-08-28 | 2016-08-29 | null | 02 | null | ENZALUTAMIDE | 101547489 |
| 20029746 | 20133198 | 1.75 | 79.2 | Curative (C) | 2018-06-17 | 2018-07-06 | null | 02 | Y | NOT MATCHED | 100787192 |
| 20029793 | 20133199 | null | null | null | 2020-09-11 | 2020-10-02 | null | 02 | null | TRIFLURIDINE + TIPIRACIL | 100755939 |
| 20029794 | 20133200 | 1.7 | 99.1 | null | 2016-09-01 | 2016-09-02 | null | 02 | null | CAPECITABINE + CISPLATIN + RT | 100507930 |
| 20029849 | 20133202 | 0 | 81.6 | null | 2017-11-06 | 2017-11-06 | null | 02 | null | LUTETIUM-177 | 101003201 |
| 20029913 | 20133203 | 1.82 | 67.2 | null | 2019-06-10 | 2019-06-26 | null | 02 | null | MITOMYCIN INTRAVESICULAR | 101471288 |
| 20029921 | 20133204 | 1.61 | 70 | null | 2019-12-19 | 2019-12-26 | null | N | null | NOT MATCHED | 100976610 |
| 20030088 | 20133207 | 1.7 | 51.7 | Palliative (P) | 2019-02-17 | 2019-02-21 | null | 02 | N | OXALIPLATIN | 101631956 |
| 20030124 | 20133208 | 1.7 | 64 | Curative (C) | 2018-03-14 | 2018-03-30 | null | 02 | Y | CAPECITABINE + CISPLATIN + EPIRUBICIN | 101223043 |
| 20030177 | 20133209 | 1.84 | 65.5 | null | 2018-04-15 | 2019-01-24 | Capecitabine + Cisplatin + RT | Y | null | CAPECITABINE + CISPLATIN + RT | 101322671 |
| 20030219 | 20133210 | 1.57 | 78 | null | 2018-02-21 | 2018-03-17 | null | 02 | null | CETUXIMAB + ENCORAFENIB | 101791800 |
| 20030288 | 20133211 | 1.63 | 72.2 | null | 2016-12-12 | 2016-12-19 | null | 1 | null | OXALIPLATIN | 100621663 |
| 20030427 | 20133213 | 1.72 | 74.6 | null | 2016-10-30 | 2016-11-06 | null | 02 | null | CAPECITABINE + CETUXIMAB + IRINOTECAN | 100460397 |
| 20030452 | 20133214 | 1.8 | 46.2 | Palliative (P) | 2016-03-29 | 2016-03-31 | null | 02 | N | PEMBROLIZUMAB | 101210463 |
| 20030480 | 20133215 | 1.61 | 84.15 | null | 2018-03-14 | 2018-04-15 | null | 02 | null | SUNITINIB | 100324300 |
| 20030547 | 20133216 | 1.68 | 62 | Curative (C) | 2017-05-07 | 2017-05-15 | null | 02 | Y | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 100865794 |